Timolol
From Wikipedia, the free encyclopedia
| Image:Timolol.png | |
| Timolol
| |
| Systematic (IUPAC) name | |
| (S)-1-(tert-butylamino)- 3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol | |
| Identifiers | |
| CAS number | 26839-75-8 |
| ATC code | C07AA06 |
| PubChem | 5478 |
| DrugBank | APRD00229 |
| Chemical data | |
| Formula | C13H24N4O3S |
| Mol. weight | 316.421 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 60% |
| Metabolism | Hepatic: 80% |
| Half life | 2.5-5 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. | |
| Legal status |
℞ Prescription only |
| Routes | oral, Ophthalmic |
Timolol maleate is a non-selective beta-adrenergic receptor blocker. In its oral form (Blocadren®), it is used to treat high blood pressure and prevent heart attacks, and occasionally to prevent migraine headaches. In its ophthalmic form (brand names Timoptol® in Italy; Timoptic®), it is used to treat open-angle and occasionally secondary glaucoma by reducing aqueous humour production through blockade of the beta receptors on the ciliary epithelium.
Contents |
[edit] Side effects
The most serious possible side effects include cardiac arrhythmias and severe bronchospasms. Timolol can also lead to fainting, stroke, congestive heart failure, depression, confusion, and impotence.
[edit] Usual Dosage
- Children and Adults: Ophthalmic: Initial: 0.25% solution, instill 1 drop twice daily; increase to 0.5% solution if response not adequate; decrease to 1 drop/day if *controlled; do not exceed 1 drop twice daily of 0.5% solution Adults: Oral:
- Hypertension: Initial: 10 mg twice daily, increase gradually every 7 days, usual dosage: 20-40 mg/day in 2 divided doses; maximum: 60 mg/day
- Prevention of myocardial infarction: 10 mg twice daily initiated within 1-4 weeks after infarction
- Migraine headache: Initial: 10 mg twice daily, increase to maximum of 30 mg/day
[edit] Formulations
- Gel-forming solution, ophthalmic, as maleate (Timoptic-XE®): 0.25% (2.5 mL, 5 mL); 0.5% (2.5 mL, 5 mL)
- Solution, ophthalmic, as hemihydrate (Betimol®): 0.25% (5 mL, 10 mL, 15 mL); 0.5% (5 mL, 10 mL, 15 mL) [contains benzalkonium chloride]
- Solution, ophthalmic, as maleate: 0.25% (5 mL, 10 mL, 15 mL); 0.5% (5 mL, 10 mL, 15 mL) [contains benzalkonium chloride]
- Timoptic®: 0.25% (5 mL, 10 mL); 0.5% (5 mL, 10 mL) [contains benzalkonium chloride]
- Solution, ophthalmic, as maleate [preservative free] (Timoptic® OcuDose®): 0.25% (0.2 mL);0.5% (0.2 mL) [single use]
- Tablet, as maleate (Blocadren®): 5 mg, 10 mg, 20 mg
[edit] Brand Names
In Canada Apo®-Timol, Apo®-Timop, Gen-Timolol®, Nu-Timolol®, Phoxal-timolol®, PMS-Timolol®, Tim-AK®. In United States Betimol®, Blocadren®, Istalol®, Timoptic® OcuDose®. In both Canada and US: Timoptic® and Timoptic-XE®.
| Beta blockers (C07) edit | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||||||
| Antiglaucoma preparations and miotics (S01E) edit | ||
|---|---|---|
| Sympathomimetics: |
Apraclonidine, Brimonidine, Clonidine, Dipivefrine, Epinephrine | |
| Parasympathomimetics: |
Aceclidine, Acetylcholine, Carbachol, Demecarium, Echothiophate, Fluostigmine, Neostigmine, Paraoxon, Physostigmine, Pilocarpine | |
| Carbonic anhydrase inhibitors: |
Acetazolamide, Brinzolamide, Diclofenamide, Dorzolamide, Methazolamide | |
| Beta blocking agents: |
Befunolol, Betaxolol, Carteolol, Levobunolol, Metipranolol, Timolol | |
| Prostaglandin analogues: | ||
| Other agents: | ||

